1. Home
  2. AFBI vs FATE Comparison

AFBI vs FATE Comparison

Compare AFBI & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AFBI

Affinity Bancshares Inc. (MD)

N/A

Current Price

$22.43

Market Cap

136.6M

Sector

Finance

ML Signal

N/A

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.78

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFBI
FATE
Founded
1928
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.6M
125.6M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
AFBI
FATE
Price
$22.43
$1.78
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$4.10
AVG Volume (30 Days)
20.2K
1.7M
Earning Date
04-24-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
55.42
29.88
EPS
1.29
N/A
Revenue
N/A
$6,646,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.86
$0.91
52 Week High
$22.50
$1.94

Technical Indicators

Market Signals
Indicator
AFBI
FATE
Relative Strength Index (RSI) 72.09 75.27
Support Level $18.62 $0.97
Resistance Level $22.47 $1.94
Average True Range (ATR) 0.03 0.11
MACD -0.09 0.03
Stochastic Oscillator 56.25 86.26

Price Performance

Historical Comparison
AFBI
FATE

About AFBI Affinity Bancshares Inc. (MD)

Affinity Bancshares Inc is a bank holding company. The bank provides a range of financial services, including checking and savings accounts, certificates of deposit, mortgage, commercial and consumer loans, and money transfer services, operating across parts of Georgia and offering specialized lending such as dental practice and indirect automobile loans across the Southeastern United States. Its business mainly involves accepting public deposits and investing them in real estate and commercial loans, as well as mortgage-backed securities. The company also gathers deposits nationwide through its virtual bank, FitnessBank, and uses additional funding sources such as Federal Home Loan Bank borrowings.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: